The round valued the AI biotech at $2 billion.
It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Cite this article
HTML citation
<a href="https://desdunia.com/startups/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials" target="_blank" rel="nofollow noopener">Enveda secures $311M to bring more nature-derived AI drugs into clinical trials</a> (Desdunia, 2026-09-23)
Markdown citation
[Enveda secures $311M to bring more nature-derived AI drugs into clinical trials](https://desdunia.com/startups/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials) — Desdunia (2026-09-23)
Plain URL
https://desdunia.com/startups/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials
Embed code
<blockquote cite="https://desdunia.com/startups/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials">Enveda secures $311M to bring more nature-derived AI drugs into clinical trials</blockquote>
<p>Source: <a href="https://desdunia.com/startups/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials" target="_blank" rel="nofollow noopener">Desdunia</a></p>